These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7940826)
1. Bone mineral content in cyclosporine-treated renal transplant patients. Massari PU; Garay G; Ulla MR Transplant Proc; 1994 Oct; 26(5):2646-8. PubMed ID: 7940826 [No Abstract] [Full Text] [Related]
2. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation. Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786 [No Abstract] [Full Text] [Related]
3. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163 [TBL] [Abstract][Full Text] [Related]
4. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation. Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609 [TBL] [Abstract][Full Text] [Related]
5. Factors involved in the loss of bone mineral density after renal transplantation. Torregrosa JV; Campistol JM; Montesinos M; Fenollosa B; Pons F; Martinez de Osaba MJ; Oppenheimer F Transplant Proc; 1995 Aug; 27(4):2224-5. PubMed ID: 7652782 [No Abstract] [Full Text] [Related]
6. Bone mineral density profile in uremic and renal transplant patients. Chao SH; Tsai KS; Chieng PU; Lee PH; Lee CJ; Lee CS Transplant Proc; 1994 Aug; 26(4):2009-11. PubMed ID: 8066651 [No Abstract] [Full Text] [Related]
9. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355 [No Abstract] [Full Text] [Related]
10. Alendronate is effective to treat bone loss in renal transplantation recipients. Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422 [TBL] [Abstract][Full Text] [Related]
11. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Chang C; Choc M Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928 [No Abstract] [Full Text] [Related]
12. Course of three biochemical bone markers after kidney transplantation. Gonzalez MT; Bonnin R; Cruzado JM; Garcia R; Moreso F; Fulladosa X; Alsina J; Navarro MA; Griñó JM Transplant Proc; 1995 Aug; 27(4):2266-71. PubMed ID: 7652802 [No Abstract] [Full Text] [Related]
13. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611 [TBL] [Abstract][Full Text] [Related]
14. Parathyroid function after successful renal transplantation. Botha JF; Botha JR S Afr J Surg; 1997 Aug; 35(3):113-6. PubMed ID: 9429326 [TBL] [Abstract][Full Text] [Related]
15. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005 [TBL] [Abstract][Full Text] [Related]
16. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792 [TBL] [Abstract][Full Text] [Related]
17. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493 [TBL] [Abstract][Full Text] [Related]
18. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Akaberi S; Lindergård B; Simonsen O; Nyberg G Transplantation; 2006 Sep; 82(6):749-52. PubMed ID: 17006320 [TBL] [Abstract][Full Text] [Related]
19. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection. Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352 [No Abstract] [Full Text] [Related]
20. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related] [Next] [New Search]